Tale of Two Drugs (IMAGE)
Caption
While dupilumab's use has been extended to children under 12, benralizumab shows no benefit to patients with eosinophilic esophagitis (EoE).
Credit
Cincinnati Children's
Usage Restrictions
none
License
Original content